These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 8030708)

  • 61. Hemolytic disease of the newborn caused by irregular blood subgroup (Kell, C, c, E, and e) incompatibilities: report of 106 cases at a tertiary-care centre.
    Karagol BS; Zenciroglu A; Okumus N; Karadag N; Dursun A; Hakan N
    Am J Perinatol; 2012 Jun; 29(6):449-54. PubMed ID: 22399212
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Successful management of severe Kell alloimmunization in pregnancy with intravenous immune globulin.
    Patris M; Holoye A; Goldman D; De Coninck C; Colard M
    Transfus Apher Sci; 2024 Apr; 63(2):103868. PubMed ID: 38238203
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Implementation of routine screening for Kell antibodies: does it improve perinatal survival?
    Kamphuis MM; Lindenburg I; van Kamp IL; Meerman RH; Kanhai HH; Oepkes D
    Transfusion; 2008 May; 48(5):953-7. PubMed ID: 18248569
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Fetal hemolytic disease due to anti-Rh17 alloimmunization.
    Hirose M; Nakanishi K; Kaku S; Moro H; Hodohara K; Aotani H; Takebayashi K; Noda Y
    Fetal Diagn Ther; 2004; 19(2):182-6. PubMed ID: 14764967
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prolonged anemia in an intrauterine-transfused neonate with Rh-hemolytic disease: no evidence for anti-D-related suppression of erythropoiesis in vitro.
    Dorn I; Schlenke P; Härtel C
    Transfusion; 2010 May; 50(5):1064-70. PubMed ID: 20003047
    [TBL] [Abstract][Full Text] [Related]  

  • 66. First case of hemolytic disease of the newborn due to anti-Ula antibodies.
    Sakuma K; Suzuki H; Ohto H; Tsuneyama H; Uchikawa M
    Vox Sang; 1994; 66(4):293-4. PubMed ID: 8079454
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Management of fetal hemolytic disease by cordocentesis. I. Prediction of fetal anemia.
    Weiner CP; Williamson RA; Wenstrom KD; Sipes SL; Grant SS; Widness JA
    Am J Obstet Gynecol; 1991 Sep; 165(3):546-53. PubMed ID: 1892178
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Death in utero due to Kell sensitization without excessive elevation of the delta OD450 value in amniotic fluid.
    Berkowitz RL; Beyth Y; Sadovsky E
    Obstet Gynecol; 1982 Dec; 60(6):746-9. PubMed ID: 7145281
    [No Abstract]   [Full Text] [Related]  

  • 69. Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999.
    van Kamp IL; Klumper FJ; Meerman RH; Oepkes D; Scherjon SA; Kanhai HH
    Acta Obstet Gynecol Scand; 2004 Aug; 83(8):731-7. PubMed ID: 15255845
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cytokines in fetal blood and amniotic fluid in Rh-immunized pregnancies.
    Westgren M; Ek S; Remberger M; Ringden O; Stangenberg M
    Obstet Gynecol; 1995 Aug; 86(2):209-13. PubMed ID: 7542377
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Chorionic biopsy in management of severe Kell alloimmunization.
    Rodesch F; Lambermont M; Donner C; Simon P; Romasco F; Schwers J; Wybran J
    Am J Obstet Gynecol; 1987 Jan; 156(1):124-5. PubMed ID: 3799745
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Follow-up of pregnancies with red-cell allo-immunisation: State-of-the art].
    Carbonne B; Castaigne V; Cynober E; Levy R; Cortey A; Mailloux A; Larsen M; Brossard Y
    Gynecol Obstet Fertil; 2010 Mar; 38(3):205-13. PubMed ID: 20207183
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Rapid and severe development of fetal hemolytic disease due to anti-Kell antibodies].
    Frère MC; Schaaps JP; Thoumsin H; Retz MC; Rif J; Rigo J; De Cortis T; Lambotte R; Senterre J; Sondag-Thull D
    Rev Med Liege; 1995 Feb; 50(2):63-6. PubMed ID: 7899747
    [No Abstract]   [Full Text] [Related]  

  • 74. Hemolytic disease of the newborn: progenitor cells and late effects.
    Luban NL
    N Engl J Med; 1998 Mar; 338(12):830-1. PubMed ID: 9504946
    [No Abstract]   [Full Text] [Related]  

  • 75. Diagnosis of fetal anemia with Doppler ultrasound in the pregnancy complicated by maternal blood group immunization.
    Mari G; Adrignolo A; Abuhamad AZ; Pirhonen J; Jones DC; Ludomirsky A; Copel JA
    Ultrasound Obstet Gynecol; 1995 Jun; 5(6):400-5. PubMed ID: 7552802
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hydrops Fetalis due to Kell Alloimmunization: A Perinatal Approach to a Rare Case.
    Akdağ A; Erdeve O; Uraş N; Simşek Y; Dilmen U
    Turk J Haematol; 2012 Mar; 29(1):72-5. PubMed ID: 24744627
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Direct relationship of fetal carboxyhemoglobin with hemolysis in alloimmunized pregnancies.
    Widness JA; Lowe LS; Stevenson DK; Vreman HJ; Weiner CP; Hayde M; Pollak A
    Pediatr Res; 1994 Jun; 35(6):713-9. PubMed ID: 7936824
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Middle cerebral artery peak systolic velocity in the prediction of fetal anemia.
    Teixeira JM; Duncan K; Letsky E; Fisk NM
    Ultrasound Obstet Gynecol; 2000 Mar; 15(3):205-8. PubMed ID: 10846775
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Reassessing critical maternal antibody threshold in RhD alloimmunization: a 16-year retrospective cohort study.
    Walsh CA; Doyle B; Quigley J; McAuliffe FM; Fitzgerald J; Mahony R; Higgins S; Carroll S; McParland P
    Ultrasound Obstet Gynecol; 2014 Dec; 44(6):669-73. PubMed ID: 24706487
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prenatal diagnosis of anoxic cerebral lesions caused by profound fetal anemia secondary to maternal red blood cell alloimmunization.
    Carbonne B; Nguyen A; Cynober E; Castaigne V; Cortey A; Brossard Y
    Obstet Gynecol; 2008 Aug; 112(2 Pt 2):442-4. PubMed ID: 18669757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.